Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 44, 2020 - Issue 4
81
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients

, , , &
Pages 272-277 | Received 10 May 2020, Accepted 23 Jun 2020, Published online: 27 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Soha R Youssef, Esraa H Hassan, Caroline S Morad, Adel A Elazab Elged & Rasha A El-Gamal. (2021) Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity?. Journal of Inflammation Research 14, pages 4445-4455.
Read now

Articles from other publishers (5)

Hiba N. Sami & Mahmoud A. M. Fakhri. (2023) BIOCHEMICAL STUDY OF SERUM β-HYDROXYBUTYRATE DEHYDROGENASE IN β-THALASSEMIA. Military Medical Science Letters 92:1, pages 2-13.
Crossref
TibaSabah Talawy, SunilKumar Bylappa, Marwan Ismail, PraveenKumar Kandakurti, Aji Gopakumar & AsaadMa Babker. (2023) Correlation of Erythroferrone and Hepcidin Hormones with Iron Status Levels in Patients with Iron Deficiency. Journal of Applied Hematology 14:1, pages 28.
Crossref
Tsz Yuen Au, Shamiram Benjamin & Oskar Wojciech Wiśniewski. (2022) Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?. Thalassemia Reports 12:3, pages 123-134.
Crossref
SamarAdnan Maatooq, MaysemMouayad Alwash & AbeerAnwer Ahmed. (2022) Comparison between H63D and G71D gene mutation effects on iron overload in Iraqi patients with β-thalassemia major: A case–control study. Iraqi Journal of Hematology 11:1, pages 60.
Crossref
Ujjwal Madan, Himani Bhasin, Pooja Dewan & Jyotsna Madan. (2021) Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon. Cureus.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.